SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000891293-17-000016
Filing Date
2017-02-09
Accepted
2017-02-09 16:59:50
Documents
1
Effectiveness Date
2017-02-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14apreliminarynoticeof.htm DEFA14A 40249
  Complete submission text file 0000891293-17-000016.txt   41355
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-28386 | Film No.: 17588330
SIC: 2834 Pharmaceutical Preparations